A Phase 1b Study of Adenylosuccinic Acid (ASA-001) for Adenylosuccinate Synthase 1 (ADSS1) Deficient Myopathy.
Clinical trial NCT07412821 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07412821
- Sponsor
- Cure ADSSL1
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-26
- Primary completion
- 2027-12-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.